With such a large spend on diagnostics R&D, Biokit wanted to ensure that this spend was utilized effectively, in order to improve efficiency within the company and, ultimately, improve patient care.
Keeping data in a range of disparate solutions created a number of challenges for Biokit. With experiment data not readily accessible and some information frequently kept in the minds of individuals – some of whom had left the company – there was the risk of having to repeat studies.
David Giles, Biokit R&D Team Leader Chemiluminescence, said: “Data is useless if it can’t be found. We were aware of the risks of misplaced information, which generated extra, often unnecessary work for the Biokit team. We needed a solution to help alleviate these risks.”